AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26695998 — intervention group
Group type: COMPARATOR
Intervention: SWC
Number of subjects: 100
Study 26695998 — intervention group
Group type: COMPARATOR
Intervention: EpiFix vs SWC
Number of subjects: 100
Study 26695998 — intervention group
Group type: COMPARATOR
Intervention: Apligraf vs SWC
Number of subjects: 100
Study 26695998 — intervention group
Group type: EXPERIMENTAL
Intervention: Apligraf vs EpiFix
Number of subjects: 100
Study 25311447 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D(3) 5000 IU daily
Number of subjects: 172
Study 25311447 — intervention group
Group type: COMPARATOR
Intervention: Oral vitamin D(3) 600 IU daily
Number of subjects: 172
Study 21787035 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patches
Number of subjects: 203
Study 21787035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 21787035 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 203
Study 21787035 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal attributions of blame
Number of subjects: 203
Study 20580618 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD-alum
Number of subjects: 0
Study 20580618 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17609429 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglustat
Number of subjects: 36
Study 17609429 — intervention group
Group type: COMPARATOR
Intervention: Imiglucerase
Number of subjects: 36
Study 17609429 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglustat alone or in combination with imiglucerase
Number of subjects: 36
Study 17609429 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy (Miglustat + Imiglucerase)
Number of subjects: 36
Study 16054737 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching program (3 times a week for 8 weeks)
Number of subjects: 19
Study 16054737 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stretching)
Number of subjects: 19
Study 12377902 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and internal fixation)
Number of subjects: 424
Study 12377902 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (ice, elevation, and rest)
Number of subjects: 424
Study 12377902 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (for patients not receiving Workers' Compensation)
Number of subjects: 424
Study 12377902 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (for women)
Number of subjects: 424
Study 12377902 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (for younger patients <29 years old with specific fracture characteristics)
Number of subjects: 424
Study 10199877 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 471
Study 10199877 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonischemic etiology of heart failure
Number of subjects: 471
Study 10199877 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic heart disease
Number of subjects: 471
Study 7552124 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic approach with conventional suture fixation
Number of subjects: 20
Study 7552124 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic approach with stapler fixation
Number of subjects: 20
Study 7552124 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraperitoneal approach with conventional suture fixation
Number of subjects: 20
Study 7552124 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraperitoneal approach with stapler fixation
Number of subjects: 20
Study 7552124 — intervention group
Group type: COMPARATOR
Intervention: Conventional abdominal Burch colposuspension
Number of subjects: 20
Study 1298802 — intervention group
Group type: EXPERIMENTAL
Intervention: Precurved endosonic files
Number of subjects: 36
Study 1298802 — intervention group
Group type: COMPARATOR
Intervention: Straight endosonic files
Number of subjects: 36
Study 6383832 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil (0.1 mg kg-1 i.v. on admission followed by 120 mg perorally t.i.d. for 6 months)
Number of subjects: 1436
Study 6383832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1436
Study 6383832 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 1436
Study 31770371 — intervention group
Group type: EXPERIMENTAL
Intervention: CHIRPY DRAGON intervention (12-month programme with 4 school- and family-based components)
Number of subjects: 1641
Study 31770371 — intervention group
Group type: EXPERIMENTAL
Intervention: CHIRPY DRAGON intervention
Number of subjects: 1641
Study 29374510 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Protein Diet (5% protein)
Number of subjects: 23
Study 29374510 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Protein Diet (15% protein)
Number of subjects: 23
Study 29374510 — intervention group
Group type: EXPERIMENTAL
Intervention: High Protein Diet (25% protein)
Number of subjects: 23
Study 29374510 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfeeding (40% increase in energy intake)
Number of subjects: 23
Study 29374510 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in short-chain fatty acyl-carnitines
Number of subjects: 23
Study 26666774 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized amphotericin B (NAB) plus nebulized budesonide (NEB)
Number of subjects: 21
Study 26666774 — intervention group
Group type: COMPARATOR
Intervention: NEB alone
Number of subjects: 21
Study 28322035 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (3 months) including physical training and psycho-educational sessions
Number of subjects: 209
Study 28322035 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program (3 months)
Number of subjects: 209
Study 28322035 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 209
Study 23586456 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment incorporating aspects of imaginal desensitization and motivational interviewing
Number of subjects: 0
Study 21144705 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy interventions (various)
Number of subjects: 10025
Study 19272497 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/DNG
Number of subjects: 1326
Study 19272497 — intervention group
Group type: EXPERIMENTAL
Intervention: EE/CPA
Number of subjects: 1326
Study 19272497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1326
Study 17317858 — intervention group
Group type: EXPERIMENTAL
Intervention: Best available drug treatment (IFN based)
Number of subjects: 354
Study 17317858 — intervention group
Group type: COMPARATOR
Intervention: Early allogeneic hematopoietic stem cell transplantation (HSCT)
Number of subjects: 354
Study 15792016 — intervention group
Group type: EXPERIMENTAL
Intervention: VIBOVITmama supplementation
Number of subjects: 0
Study 15792016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11574441 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidarestat (1 mg daily for 52 weeks)
Number of subjects: 279
Study 11574441 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 279
Study 9663359 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone 50 micrograms BID
Number of subjects: 263
Study 9663359 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone 100 micrograms BID
Number of subjects: 263
Study 9663359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 8800732 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy plus methotrexate (n = 17)
Number of subjects: 36
Study 8800732 — intervention group
Group type: COMPARATOR
Intervention: Quadruple therapy (n = 19)
Number of subjects: 36
Study 1964678 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 160 micrograms/kg
Number of subjects: 56
Study 1964678 — intervention group
Group type: COMPARATOR
Intervention: Granisetron 40 micrograms/kg
Number of subjects: 56
Study 1964678 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (40‐240 micrograms/kg over a 24 hour period)
Number of subjects: 56
Study 6444241 — intervention group
Group type: EXPERIMENTAL
Intervention: Cl2MDP (dichloromethylene diphosphonate) for eight weeks
Number of subjects: 10
Study 6444241 — intervention group
Group type: COMPARATOR
Intervention: Placebo for eight weeks
Number of subjects: 10
Study 30485665 — intervention group
Group type: EXPERIMENTAL
Intervention: Omaha System-based discharge guidance
Number of subjects: 150
Study 30485665 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 150
Study 27760494 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercuspal Position (ICP)
Number of subjects: 87
Study 27760494 — intervention group
Group type: COMPARATOR
Intervention: Blocked Occlusion (BO)
Number of subjects: 87
Study 27760494 — intervention group
Group type: EXPERIMENTAL
Intervention: Angle-class, midline-displacement, crossbite, or orthodontic therapy
Number of subjects: 87
Study 25775223 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 60
Study 25775223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 23274597 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.8 mg·kg BM of PSE
Number of subjects: 10
Study 23274597 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10
Study 21088211 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary salt intake (128 mmol sodium/day)
Number of subjects: 10
Study 21088211 — intervention group
Group type: COMPARATOR
Intervention: Low dietary salt intake (60‐80 mmol sodium/day)
Number of subjects: 10
Study 19350123 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 477
Study 19350123 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 477
Study 19350123 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 477
Study 17369520 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular electrical stimulation (n = 32)
Number of subjects: 61
Study 17369520 — intervention group
Group type: COMPARATOR
Intervention: Hemisling (n = 29)
Number of subjects: 61
Study 15099280 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin for 3 months
Number of subjects: 165
Study 15099280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 15099280 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin for 1 month
Number of subjects: 165
Study 11283878 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused abdominal sonography for trauma (FAST)
Number of subjects: 160
Study 11283878 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 160
Study 9087653 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal electric stimulation at frequencies ranging from 0.1 to 1 Hz
Number of subjects: 13
Study 9087653 — intervention group
Group type: COMPARATOR
Intervention: Baseline respiratory rate
Number of subjects: 13
Study 7899112 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunization in the ED
Number of subjects: 40
Study 7899112 — intervention group
Group type: COMPARATOR
Intervention: Control group (no immunization in the ED)
Number of subjects: 40
Study 2187174 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital prophylaxis
Number of subjects: 228
Study 2187174 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 228
Study 2187174 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventriculomegaly
Number of subjects: 228
Study 2187174 — intervention group
Group type: EXPERIMENTAL
Intervention: Periventricular-intraventricular hemorrhage
Number of subjects: 228
Study 2187174 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenchymal hemorrhage
Number of subjects: 228
Study 619055 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics (ampicillin, cephalexin, cloxacillin, dicloxacillin, penicillin G)
Number of subjects: 21
Study 30862377 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty
Number of subjects: 718
Study 30862377 — intervention group
Group type: COMPARATOR
Intervention: Eye drops
Number of subjects: 718
Study 28165771 — intervention group
Group type: EXPERIMENTAL
Intervention: SIPsmartER intervention
Number of subjects: 155
Study 28165771 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR models
Number of subjects: 155
Study 25170553 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent human papillomavirus vaccine (HPV4) before concomitantly administered vaccines
Number of subjects: 0
Study 25170553 — intervention group
Group type: COMPARATOR
Intervention: Quadrivalent human papillomavirus vaccine (HPV4) after concomitantly administered vaccines
Number of subjects: 0
Study 24392550 — intervention group
Group type: EXPERIMENTAL
Intervention: Note-taking skills training
Number of subjects: 110
Study 24392550 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 110
Study 21806852 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant-rich diet
Number of subjects: 102
Study 21806852 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiwi fruit diet
Number of subjects: 102
Study 21806852 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 19861932 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of body mass changes
Number of subjects: 0
Study 19861932 — intervention group
Group type: COMPARATOR
Intervention: Bioimpedance and urine specific gravity
Number of subjects: 0
Study 16903595 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion treatment
Number of subjects: 560
Study 16903595 — intervention group
Group type: COMPARATOR
Intervention: Prozac-20
Number of subjects: 560
Study 15373869 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration
Number of subjects: 30
Study 15373869 — intervention group
Group type: COMPARATOR
Intervention: Topical spray
Number of subjects: 30
Study 11282757 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (20 min)
Number of subjects: 14
Study 11282757 — intervention group
Group type: COMPARATOR
Intervention: Control (8 subjects)
Number of subjects: 14
Study 9449301 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder training for 6 weeks
Number of subjects: 123
Study 7653745 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SC) 10 mg four times daily
Number of subjects: 37
Study 7653745 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) 100 micrograms four times daily
Number of subjects: 37
Study 2892143 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg daily) + Hydrochlorothiazide (50 mg daily)
Number of subjects: 0
Study 2892143 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg daily) + Atenolol (50 mg daily)
Number of subjects: 0
Study 2892143 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers and Diuretics
Number of subjects: 0
Study 29631764 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin temperature over myofascial trigger points in the upper trapezius muscle
Number of subjects: 40
Study 26783268 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticle suspension (CNPS)
Number of subjects: 156
Study 26783268 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 156
Study 24323568 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute inflammation at baseline biopsy
Number of subjects: 6238
Study 24323568 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic inflammation at baseline biopsy
Number of subjects: 6238
Study 24323568 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute inflammation at 4-year biopsy
Number of subjects: 6238
Study 23849325 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg nifedipine and 32 mg candesartan FDC
Number of subjects: 49
Study 23849325 — intervention group
Group type: COMPARATOR
Intervention: Loose combination of 60 mg nifedipine GITS and 32 mg candesartan
Number of subjects: 49
Study 23849325 — intervention group
Group type: COMPARATOR
Intervention: 60 mg nifedipine GITS alone
Number of subjects: 49
Study 23849325 — intervention group
Group type: COMPARATOR
Intervention: 32 mg candesartan alone
Number of subjects: 49
Study 20004740 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted physical activity sessions during hospitalization
Number of subjects: 0
Study 19047883 — intervention group
Group type: EXPERIMENTAL
Intervention: Data-based system (Sabacare Clinical Care Classification System)
Number of subjects: 0
Study 19047883 — intervention group
Group type: COMPARATOR
Intervention: Type-in text-based system
Number of subjects: 0
Study 16724230 — intervention group
Group type: EXPERIMENTAL
Intervention: ADIPOR1 gene variations (specifically SNPs rs10920534, rs22757538, rs1342387)
Number of subjects: 0
Study 16724230 — intervention group
Group type: EXPERIMENTAL
Intervention: ADIPOR1 gene variations (specifically SNPs rs10920534, rs12045862, rs7539542)
Number of subjects: 0
Study 16724230 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype analysis with five markers
Number of subjects: 0
Study 12925476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 0.2 mg
Number of subjects: 200
Study 12925476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 0.3 mg
Number of subjects: 200
Study 12925476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 0.4 mg
Number of subjects: 200
Study 12925476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine 0.5 mg
Number of subjects: 200
Study 12925476 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal diamorphine (all doses)
Number of subjects: 200
Study 10814655 — intervention group
Group type: COMPARATOR
Intervention: Simple advice (group A)
Number of subjects: 1095
Study 10814655 — intervention group
Group type: EXPERIMENTAL
Intervention: More active programme (group B)
Number of subjects: 1095
Study 9007178 — intervention group
Group type: EXPERIMENTAL
Intervention: MCT/LCT emulsion
Number of subjects: 44
Study 9007178 — intervention group
Group type: EXPERIMENTAL
Intervention: LCT emulsion
Number of subjects: 44
Study 9007178 — intervention group
Group type: COMPARATOR
Intervention: Glucose-saline
Number of subjects: 44
Study 1743661 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (279 patients, 153 enrolled in CPS)
Number of subjects: 1587
Study 1743661 — intervention group
Group type: COMPARATOR
Intervention: Control group (143 patients)
Number of subjects: 1587
Study 6360298 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystoscopy and Otis urethrotomy
Number of subjects: 64
Study 6360298 — intervention group
Group type: COMPARATOR
Intervention: Cystoscopy alone
Number of subjects: 64
Study 31888543 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction techniques
Number of subjects: 68
Study 31888543 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study 28987981 — intervention group
Group type: EXPERIMENTAL
Intervention: Complicated Grief (CG)
Number of subjects: 0
Study 28987981 — intervention group
Group type: EXPERIMENTAL
Intervention: Current major depression (DEPRESSED)
Number of subjects: 0
Study 28987981 — intervention group
Group type: COMPARATOR
Intervention: Controls (CONTROLS)
Number of subjects: 0
Study 27466239 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for smoking abstinence (vouchers increasing with duration of abstinence)
Number of subjects: 0
Study 27466239 — intervention group
Group type: COMPARATOR
Intervention: €20 vouchers at each visit (control group)
Number of subjects: 0
Study 25225436 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg once per day
Number of subjects: 940
Study 25225436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 940
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach motivation with goal reference line
Number of subjects: 0
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidance motivation with goal reference line
Number of subjects: 0
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic approach motivation
Number of subjects: 0
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic avoidance motivation
Number of subjects: 0
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated approach motivation
Number of subjects: 0
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated avoidance motivation
Number of subjects: 0
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-focused health message
Number of subjects: 0
Study 22468423 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-focused health message
Number of subjects: 0
Study 19718941 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritually based educational intervention
Number of subjects: 0
Study 19718941 — intervention group
Group type: COMPARATOR
Intervention: Non-spiritually based educational intervention
Number of subjects: 0
Study 17617287 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg packet (sachet) formulation
Number of subjects: 96
Study 15669599 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye contact
Number of subjects: 76
Study 15669599 — intervention group
Group type: EXPERIMENTAL
Intervention: Stare technique (20 to 30 seconds after command)
Number of subjects: 76
Study 15669599 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study 12533060 — intervention group
Group type: EXPERIMENTAL
Intervention: Trillium-coated Affinity open reservoir oxygenator
Number of subjects: 98
Study 12533060 — intervention group
Group type: COMPARATOR
Intervention: Uncoated Affinity open reservoir oxygenator
Number of subjects: 98
Study 9523865 — intervention group
Group type: EXPERIMENTAL
Intervention: F13 (13 g/l protein)
Number of subjects: 5
Study 9523865 — intervention group
Group type: EXPERIMENTAL
Intervention: F15 (15 g/l protein)
Number of subjects: 5
Study 9523865 — intervention group
Group type: EXPERIMENTAL
Intervention: F18 (18 g/l protein)
Number of subjects: 5
Study 9523865 — intervention group
Group type: COMPARATOR
Intervention: B (breast-fed)
Number of subjects: 5
Study 9523865 — intervention group
Group type: COMPARATOR
Intervention: M (mixed-fed)
Number of subjects: 5